tirzepatide surmount 2 adolescent obesity trial once weekly for the treatment of in people with type diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 Tirzepatide for the Maintenance of – Tirzepatide 10 and 15 mg

Individual results are not guaranteed

Integrated approach to weight management combines medication with nutritional guidance, lifestyle coaching, and support for sustainable results

[DOI] [PubMed] [Google Scholar] [100].Wilding JPH, Batterham RL, Calanna S, et al

9 This was a 72-week double blind, randomized, placebo-controlled phase 3 trial comparing tirzepatide 5mg, 10mg, and 15mg to placebo

Alhassani RY, Bagadood RM, Balubaid RN, Barno HI, Alahmadi MO, Ayoub NA

It is essential in many body processes, including increasing antioxidant effects, reproduction, and reducing the risk of high blood pressure during pregnancy